Mutations in the TREM2 gene have been associated with an increased risk of developing late-onset Alzheimer’s disease [70], probably through a reduced microglial ability to clear Aβ, impairing the inflammatory response [15]. This evidence concerns the gene TREM2 and early-onset autosomal dominant Alzheimer disease.